[
Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital
[og_img]
https://www.investing.com/news/press-releases/estrella-immunopharma-inc-nasdaq-esla-eslaw-receives-buy-rating-with-a-12month-price-target-of-1600-from-d-boral-capital-93CH-3878669
Investing.com
Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital
Related articles
